Hematopathology Update Course Covering WHO 5th Edition and ICC Classification
The Hematopathology Update Course 2026 is a hematopathology update course produced by USCAP, delivered as 24 video modules plus course documents, released August 1, 2026, offering 24 AMA PRA Category 1 Credits. The program reviews morphologic diagnosis of lymphoid and myeloid neoplasms and applies both WHO 5th Edition and International Consensus Classification (ICC) criteria to everyday diagnostic practice.
-
24Modules
-
24CME Credits
-
2026Release Year
Inside this resource
Lymphoid Neoplasm Diagnosis
Modules on reactive lymph nodes, plasma cell neoplasms, B-cell and T-cell lymphomas, Hodgkin lymphoma, and DLBCL cover the diagnostic spectrum of lymphoid pathology.
Myeloid Neoplasm Classification
Sessions address acute myeloid leukemia, myelodysplastic and myeloproliferative neoplasms, systemic mastocytosis, and pediatric myeloid disorders under WHO 5th Edition criteria.
WHO 5th Edition and ICC Application
The course applies both WHO 5th Edition and International Consensus Classification systems, including cases where the two frameworks produce different diagnoses.
Panel Q&A and Case Discussion
Panel Q&A sessions address practical, challenging hematopathology cases alongside the structured module content.
Who this serves
- Practicing and academic pathologists — the course is explicitly designed for practicing, academic, and community pathologists.
- Hematopathologists and pathology fellows — hematopathology fellows and hematopathologists are named as a target audience.
- Pathology residents preparing for boards — the source lists physicians preparing for pathology board examinations or continuing certification.
Faculty & syllabus
Faculty 8 speakers
Named faculty (credentials as given in source data):
- Amy Chadburn, MD — Reactive lymph nodes; Burkitt and high-grade lymphoma/DLBCL; immunodeficiency-associated lymphomas.
- Robert Lorsbach, MD, PhD — Plasma cell neoplasms; pediatric myeloid neoplasms; B- and T-lymphoblastic leukemia/lymphoma.
- Laurence L. de Leval, MD, PhD — Bone marrow B-cell lymphomas; peripheral T-cell lymphoma.
- Ioannis Anagnostopoulos, MD — Follicular and nodal marginal zone lymphoma; Hodgkin lymphoma.
- Judith A. Ferry, MD — Extranodal and splenic B-cell lymphomas; DLBCL variants; cutaneous lymphomas.
- Robert P. Hasserjian, MD — Non-neoplastic bone marrow conditions; myelodysplastic syndromes; progressed/treated myeloid neoplasms.
- Daniel A. Arber, MD — Myeloproliferative neoplasms; systemic mastocytosis; MDS/MPN overlap disorders.
- Joseph D. Khoury, MD — Acute myeloid leukemia; histiocytic and dendritic neoplasms; mixed phenotype acute leukemia.
Before you buy
What does this course cover?
24 video modules covering lymphoid and myeloid neoplasm diagnosis, WHO 5th Edition and ICC classification, and ancillary testing, plus course documents and panel Q&A.
How much CME credit does it offer?
24 AMA PRA Category 1 Credits, released August 1, 2026.
The chart
| Format | Video presentations + course documents/PDFs |
|---|---|
| Duration | 24 modules |
| Faculty | 8+ named faculty |
| Year | 2026 |
| Publisher | USCAP (United States and Canadian Academy of Pathology) |
| Department | Pathology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout


Reviews
There are no reviews yet.